Results 31 to 40 of about 480,913 (287)

Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives

open access: yesOncoTarget, 2018
Anticancer drugs may have proarrhythmic effects including drug-induced QT interval prolongation, which is of particular importance because it can lead to a fatal polymorphic ventricular tachycardia termed torsade de pointes (TdP).
Jialin Duan   +8 more
semanticscholar   +1 more source

Adverse reactions of amiodarone [PDF]

open access: yes, 2019
Adverse drug reaction is defined by the World Health Organization as any response to a drug that is noxious and unintended and occurs at a dose normally used in man.
Calvosa, Leonardo   +5 more
core   +1 more source

Intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: Evidences from proarrhythmia model and action-potential assay

open access: yesJournal of Pharmacological Sciences, 2016
We evaluated proarrhythmic risk of intravenous oseltamivir with chronic atrioventricular block canine model (n = 4) and action-potential assay on guinea-pig right ventricle (n = 5). Oseltamivir in doses of 3–30 mg/kg, i.v.
Yuji Nakamura   +9 more
doaj   +1 more source

Torsade de pointes [PDF]

open access: yesClinical Cardiology, 1993
AbstractThe polymorphic ventricular tachycardia torsade de pointes can occur in the congenital long QT syndromes or as a consequence of therapy with QT‐prolonging drugs. The latter can include not only antiarrhythmic drugs such as quinidine, but also a number of drugs which are not usually considered to have major cardiovascular effects: these include ...
openaire   +2 more sources

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project [PDF]

open access: yes, 2015
Introduction: Spontaneous reporting systems (SRSs) are pivotal for signal detection, especially for rare events with a high drug-attributable component, such as torsade de pointes (TdP).
Antoniazzi, S. (Stefania)   +12 more
core   +7 more sources

Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug

open access: yesPharmacology Research & Perspectives, 2017
Several noncardiac drugs have been linked to cardiac safety concerns, highlighting the importance of post‐marketing surveillance and continued evaluation of the benefit‐risk of long‐established drugs.
A. Schlit   +9 more
semanticscholar   +1 more source

Long QT Syndrome and Perioperative Torsades de Pointes: What the Anesthesiologist Should Know.

open access: yesJournal of Cardiothoracic and Vascular Anesthesia, 2020
Perioperative Torsade de Pointes (TdP) is a potentially fatal arrhythmia. The association between the prolongation of corrected QT (QTc) interval and TdP has been well described, but prolonged QTc interval is likely not to be a sole determinant.
N. Niimi   +2 more
semanticscholar   +1 more source

Predictive Value of Tpeak – Tend Indices for Adverse Outcomes in Acquired QT Prolongation: A Meta-Analysis

open access: yesFrontiers in Physiology, 2018
Background: Acquired QT interval prolongation has been linked with malignant ventricular arrhythmias, such as torsade de pointes, in turn predisposing to sudden cardiac death. Increased dispersion of repolarization has been identified as a pro-arrhythmic
Gary Tse   +13 more
doaj   +1 more source

Hypocalcemic torsades de pointes

open access: yesJournal of Electrocardiology, 1989
Torsades de pointes is a unique form of ventricular tachycardia that occurs in the presence of prolonged QT interval. Many predisposing factors have been identified. A classical form of torsades de pointes occurring in the presence of hypocalcemia and prolonged QT interval in an elderly woman is reported.
T, Akiyama   +4 more
openaire   +2 more sources

Spatial patterns of excitation at tissue and whole organ level due to early afterdepolarizations [PDF]

open access: yes, 2017
Early after depolarizations (EAD) occur in many pathological conditions, such as congenital or acquired channelopathies, drug induced arrhythmias, and several other situations that are associated with increased arrhythmogenicity. In this paper we present
Alexander V. Panfilov   +4 more
core   +3 more sources

Home - About - Disclaimer - Privacy